Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-19T08:16:41.534Z Has data issue: false hasContentIssue false

Cortisol-binding globulin levels in bipolar disorder

Published online by Cambridge University Press:  16 April 2020

E Vieta
Affiliation:
Department of Psychiatry, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona, Spain
C Gastó
Affiliation:
Department of Psychiatry, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona, Spain
MJ Martínez de Osaba
Affiliation:
Hormonal Laboratory, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona
A Otero
Affiliation:
Department of Psychiatry, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona, Spain
E Nieto
Affiliation:
Department of Psychiatry, Hospital de Manresa, Manresa
L Pintor
Affiliation:
Department of Psychiatry, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona, Spain
J Blanch
Affiliation:
Department of Psychiatry, Hospital Clinic, University of Barcelona, Villarroel 170, 08036Barcelona, Spain
J Vallejo
Affiliation:
Department of Psychiatry, Hospital de Bellvitge, University of Barcelona, Barcelona, Spain
Get access

Summary

Cortisol-binding globulin (CBG) is an alpha-1-glycoprotein with high affinity for cortiso that could be a potential biological marker of chronic stress, according to several previous studies. In order to examine CBG concentrations in bipolar disorder, we determined serum CBG levels by radioimmunoassay with monoclonal antibodies in a sample of 39 RDC bipolar I patients in remission and 21 healthy age-, sex- and weight-matched control subjects. Only lithium treatment was permitted. Plasma cortisol and serum lithium levels were also determined. Bipolar males showed statistically significant lower serum CBG levels than controls, whereas women showed very similar values. No correlation was found between CBG levels and cortisol or lithium concentrations. It is concluded that CBG levels are affected by chronic affective illness, even during remission periods, at least in bipolar males.

Type
Original article
Copyright
Copyright © Elsevier, Paris 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Armario, A, Giralt, M, Marti, O, et al.The effect of acute and chronic ACTH administration on pituitary-adrenal response to acute immobilization stress. Relationship to changes in corticosteroid-bi. Endocr Res Commun 1994; 20: 139149CrossRefGoogle Scholar
Bernutz, C, Horn, K, Pickardt, CR. Characterization of isolated corticosteroid binding globulin (CBG) and radioimmunological determination in human serum Acta Endocrinol (Copenh) 87Suppl 2151978 2526Google Scholar
Brien, TG. Human corticosteroid binding globulin. Clin Endocrinol (Oxf) 1981; 14: 19321210.1111/j.1365-2265.1981.tb00616.xCrossRefGoogle ScholarPubMed
Coolens, JL, Van Baelen, H, Hergus, W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987; 26: 197202CrossRefGoogle ScholarPubMed
Cosgriff, JP, Abbott, RM, Oakley-Browne, MA, Joyce, PR. Cortisol hypersecretion predicts early depressive relapse after recovery with electroconvulsive therapy. Biol Psychiatry 1990; 28: 10071010CrossRefGoogle ScholarPubMed
De Moor, P, Steeno, O, Brosens, I, Hendrikx, A. Data on transcortin activity in human plasma as studied by gel filtration. J Clin Endocrinol Metab 1966; 26: 717810.1210/jcem-26-1-71CrossRefGoogle ScholarPubMed
Doe, R, Fernández, R, Seal, US. Measurement of corticosteroid-binding globulin in man. J Clin Endocrinol Metab 1964; 24: 10291039CrossRefGoogle ScholarPubMed
Doe, R, Lohrenz, F, River, G, Dosherholmen, A, Roberts, R. Vitamin B12 deficiency: a heretofore undescribed control mechanism for plasma corticosteroid-binding globulin concentration in man. J Clin Endocrinol Metab 1982; 54: 381385CrossRefGoogle ScholarPubMed
Dorus, E, Pandey, GN, Shaughnessy, R, Davis, JM. Low platelet monoamine oxidase activity, high red blood cell lithium ratio, and affective disorders: a multivariate assessment of genetic vulnerability to aff. Biol Psychiatry 1979; 14: 989993Google Scholar
Endicott, J, Spitzer, R. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35: 83784410.1001/archpsyc.1978.01770310043002CrossRefGoogle Scholar
Faict, D, De Moor, P. Use of monoclonal antibodies in a RIA for human transcortin. Clin Chem 1984; 30: 369372CrossRefGoogle Scholar
Gastó, C, Vallejo, JBiología de los trastornos afectivosVallejo, J, Gastó, CTrastornos afectivos: ansiedad y depresión 19 Barcelona: Salvat, 1990; 311349Google Scholar
Kathol, RG. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressed patients: a trait finding. J Affective Disord 1985; 8: 13714510.1016/0165-0327(85)90036-9CrossRefGoogle ScholarPubMed
King, DJ. Plasma cortisol-binding capacity in mental illness. Psychol Med 1973; 3: 5365CrossRefGoogle ScholarPubMed
Leake, A, Griffiths, HW, Pascual, JA, Ferrier, IN. Corticosteroid-binding globulin in depression. Clin Endocrinol (Oxf) 1989; 30: 3945CrossRefGoogle ScholarPubMed
Lewy, AJ, Nurnberger, JI, Wehr, TA, et al.Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry 1985; 142: 725727Google ScholarPubMed
Maes, M, Wauters, A, Neels, H, et al.Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity. J Affective Disord 1995; 34: 6169CrossRefGoogle ScholarPubMed
Menchón, JM, Gastó, C, Vallejo, J, Catalán, R, Otero, A, Vieta, E. Rate and significance of hypomanic switches in unipolar melancholic depression. Eur Psychiatry 1993; 8: 12512910.1017/S0924933800001905CrossRefGoogle Scholar
Nasman, B, Olsson, T, Seckl, JR, et al.Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendocrinology 1995; 20: 839410.1016/0306-4530(94)E0044-ACrossRefGoogle Scholar
Nemeroff, CB, Evans, DL. Correlation between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 1984; 141: 247249Google ScholarPubMed
Racadot, A, Racadot-Leroy, N, Le Gaillard, F, Dautrevaux, M. Dosage de la transcortine sérique par électroimmuno-diffusion. Clin Chim Acta 1976; 66: 17118010.1016/0009-8981(76)90054-1CrossRefGoogle Scholar
Rosner, W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev 1990; 11: 8091CrossRefGoogle ScholarPubMed
Sitaram, N, Nurnberger, JI Jr, Gershon, ES, Gillin, JC. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science 1980; 208: 20020210.1126/science.7361118CrossRefGoogle ScholarPubMed
Spitzer, RL, Endicott, J, Robins, E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 77378210.1001/archpsyc.1978.01770300115013CrossRefGoogle ScholarPubMed
Sueda, K, Ogawa, K, Matsui, N. Radioimmunoassay of human transcortin. Endocrinol Jpn 1983; 30: 737745CrossRefGoogle ScholarPubMed
Vieta, E, Gastó, C. La enfermedad bipolar. Med Clin (Barc) 1995; 105: 136138Google Scholar
Vieta, E, Gastó, C, Martínez-de-Osaba, MJ, et al.Prediction of depressive relapse in remitted bipolar patients using corticotropin-releasing hormone challenge test Acta Psychiatr Scand 1996Google Scholar
Zouaghi, H, Savu, L, Delorme, J, Kleinknecht, D, Nuñez, E. Loss of serum transcortin in human shock associated with severe infection by Candida albicans. Acta Endocrinol (Copenh) 1983; 102: 27728310.1530/acta.0.1020277CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.